Related Experiment Video
Updated: Aug 23, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
Yaqiong Zhou1,2, Dan Wang1,2, Qiting Liu1,2
1Department of Cardiology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Superselective adrenal arterial embolization offers a new treatment for primary aldosteronism. This minimally invasive procedure effectively controlled hypertension and improved cardiac function in a patient refusing surgery.
Area of Science:
- Endocrinology
- Interventional Radiology
Background:
- Primary aldosteronism is a frequent cause of difficult-to-treat hypertension.
- Treatment options include surgery or medication, but adherence and efficacy can be challenging.
- Superselective adrenal arterial embolization presents a minimally invasive alternative.
Observation:
- A 39-year-old male with a 5-year history of primary aldosteronism and resistant hypertension refused adrenalectomy.
- Despite adequate medical therapy, the patient experienced hypokalemia, poor blood pressure control, left ventricular hypertrophy, and renal dysfunction.
- Aldosterone-producing adenoma in the left adrenal gland was confirmed.
Findings:
- Superselective embolization of the left middle adrenal artery supplying the adenoma was performed using 2 ml of ethanol.
- This procedure normalized blood pressure for 3 months and reversed left ventricular hypertrophy.
- The patient's symptoms and complications significantly improved.
Implications:
- Superselective adrenal arterial embolization is a viable alternative for patients with aldosterone-producing adenoma who decline surgery.
- This interventional technique may offer a less invasive approach to managing primary aldosteronism.
- Further research is warranted to establish long-term efficacy and safety profiles.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Peripheral Artery Disease III: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

